Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 29NIH 19NETWORK 7INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5CNS 1

Conditions

Arthritis, Rheumatoid 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Graft vs Host Disease 6Leukemia 5Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Myelodysplastic Syndromes 3Lymphoma 3Psoriasis 2Neoplasms 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Burkitt Lymphoma 2Urinary Bladder Neoplasms 1Stomatitis 1Recurrence 1Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1Neutropenia 1Mycosis Fungoides 1Multiple Myeloma 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoproliferative Disorders 1

Interventions

Trastuzumab 209Paclitaxel 187Fulvestrant 161Capecitabine 150Docetaxel 136Letrozole 127exemestane 92palbociclib 76Anastrozole 75Cyclophosphamide 71Lapatinib 69Gemcitabine 66Bevacizumab 66pertuzumab 61pembrolizumab 60ribociclib 59Carboplatin 59abemaciclib 53eribulin 48Doxorubicin 45Vinorelbine 41Everolimus 41Ado-Trastuzumab Emtansine 41Tamoxifen 40130-nm albumin-bound paclitaxel 34Injections 31trastuzumab deruxtecan 30Albumin-Bound Paclitaxel 26olaparib 24Alpelisib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms × Methotrexate × Clear all
NCT03613181 2023-04-24

ANGLeD

Angiochem Inc

Phase 3 Unknown
150 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT00152178 2011-07-07

The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
680 enrolled
Breast

Breast Neoplasms

NCT00152191 2011-07-07

A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC)

Taiho Pharmaceutical Co., Ltd.

Phase 3 Completed
1,300 enrolled
Breast

Breast Neoplasms

NCT00124111 2010-02-26

A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer

Amgen

Phase 2 Completed
Breast

Breast Neoplasms, Neoplasms, Neutropenia

NCT00174707 2009-12-07

Study of Docetaxel in Breast Cancer Patients

Sanofi

Phase 3 Completed
998 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡